Unlock instant, AI-driven research and patent intelligence for your innovation.

Detection reagent for non-small cell lung cancer

A technology for non-small cell lung cancer and detection reagents, applied in the field of single-stranded non-coding small molecule RNA, which can solve the problems of patients losing treatment opportunities and other issues

Pending Publication Date: 2021-08-13
DALIAN MEDICAL UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the occurrence of lung cancer is relatively hidden, and patients usually have no obvious symptoms in the early stage, which makes some patients lose the best opportunity for treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection reagent for non-small cell lung cancer
  • Detection reagent for non-small cell lung cancer
  • Detection reagent for non-small cell lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Serum samples from patients with non-small cell lung cancer and healthy controls were used for high-throughput miRNA sequencing and analysis. The experimental steps are as follows.

[0047] 1) Serum samples were mixed and placed in 10mL EP tubes. Tissue samples were frozen in liquid nitrogen and stored at -80°C.

[0048] 2) Randomly select 4 samples from each of the collected non-small cell lung cancer serum samples in stage I, stage II, stage III, and stage IV and 4 serum samples from normal healthy controls. Shanghai Kangcheng Bioengineering Co., Ltd. conducts serum miRNA high pass Quantitative sequencing and analysis were performed to screen out miRNAs differentially expressed in non-small cell lung cancer serum samples.

[0049] The present inventors found that a single-stranded non-coding small molecule RNA Lci-miRNA is highly expressed in serum samples of non-small cell lung cancer.

[0050] figure 1 Indicates the expression results of Lci-miRNA detected by hig...

Embodiment 2

[0055] Real-time fluorescent quantitative PCR detection of Lci-miRNA. The experimental steps are as follows.

[0056] 1) When the sample is a human serum sample, use the adsorption column method and use miRcute Serum / Plasma miRNA Extraction and Separation Kit DP503 from TIANGEN to extract serum total RNA; when the sample is human tumor tissue, For human paracancerous tissue samples or human normal tissue samples, use the TRIzol method and use TAKARA RNAiso Plus9109 to extract total RNA from tissue samples.

[0057] 2) Use Thermo Fisher NanoDrop 2000 to measure the concentration and purity of RNA, and use formaldehyde denaturing gel electrophoresis for quality inspection to ensure the integrity of the extracted RNA.

[0058] 3) Using the extracted total RNA as a template, according to the one-step method, use HaiGene TaqMan miRNA Reverse Transcription Kit D1801 of Harbin Beiguo Haiji Biotechnology Co., Ltd. to perform reverse transcription to synthesize cDNA. The reaction syst...

Embodiment 3

[0071] Detection of Lci-miRNA expression in non-small cell lung cancer cell lines. The cells used in this example are all from the Cell Bank of the Type Culture Collection Committee of the Chinese Academy of Sciences. The experimental steps are as follows.

[0072] 1) Take the cells (normal human bronchial epithelial cells HBE, human non-small cell lung cancer cell lines A549, NCI-H1299, NCI-H1975 and EPLC-32M1) out of the liquid nitrogen and quickly put them into the opened in advance and set the temperature to In a water bath at 37°C, gently shake the cryotube left and right for about 1 minute, observe that the cells in the cryotube are completely thawed, and then sterilize the countertop of the ultra-clean workbench with 75% alcohol and transfer the cells to the super-clean workbench in the ultra-clean workbench. Put 2mL of GIBCO RPMI-1640 (C11875500BT) medium in a 15mL centrifuge tube, centrifuge at 1000rpm for 3min, discard the supernatant, and add fresh RPMI-1640 comple...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a detection reagent for non-small cell lung cancer. The detection reagent is characterized in that the detection reagent for non-small cell lung cancer is used for detecting a single-stranded non-coding small molecule RNA with a nucleotide sequence as shown in sequence 1 in a sequence table. The non-coding single-stranded small-molecule RNA is a newly discovered miRNA, shows a specific high expression phenomenon in serum, tissues and non-small cell lung cancer cell lines of a patient with non-small cell lung cancer, and can be used as a tumor marker of the non-small cell lung cancer. The detection reagent for non-small cell lung cancer can provide a non-invasive and non-radiation detection method for non-small cell lung cancer with high detection sensitivity and specificity.

Description

technical field [0001] The present invention relates to a new non-small cell lung cancer detection reagent, in particular to a newly discovered single-stranded non-coding small molecule RNA, which can be used as a non-small cell lung cancer tumor marker for the detection of non-small cell lung cancer . Background technique [0002] Lung cancer is one of the malignant tumors that seriously endanger human health. The 2015 "China Malignant Oncology Development Report" shows that lung cancer ranks first in the incidence of male tumors (24.17%), and the incidence of lung cancer in female tumors is 15.02%, second only to breast cancer (17.10%). The mortality rate of lung cancer ranks first in both men and women, among which men account for 29.28% and women account for about 22.96%. In 2015, the number of deaths due to lung cancer in my country was about 631,000, and the mortality rate was 45.87 / 100,000. The overall 5-year survival rate of lung cancer patients is only 5.8%, whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12Q1/686C12N15/113
CPCC12Q1/6886C12Q1/686C12Q2600/158
Inventor 吴英杰刘波王宁李瑞华汪飞刘向东柏杨冉丽媛郭美华姜茹娇孙杰邱瑞娇
Owner DALIAN MEDICAL UNIVERSITY